7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Polycythemia Vera D011087 13 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Cardiomyopathies D009202 10 associated lipids
Disease Susceptibility D004198 12 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Tortelli F et al. Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. 2009 Tissue Eng Part A pmid:19292676
Hasegawa T et al. Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. 2002 Tissue Cell pmid:11989970
Carda C et al. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint. 2005 Tissue Cell pmid:15899507
Mikosch P et al. High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy. 2008 Thyroid pmid:18302515
Martini G et al. The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. 2008 Thyroid pmid:18399769
Vinholt PJ et al. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. 2013 Thromb. Res. pmid:23531238
Guldiken B et al. Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. 2007 Thromb. Res. pmid:17258300
Hyseni A et al. Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. 2013 Thromb. Res. pmid:23273402
Vik A et al. Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. 2012 Thromb. Res. pmid:22909822
O'Sullivan EP et al. Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. 2010 Thromb. Res. pmid:20932553

Table of Content